Thursday 9 November 2017

Commercial drone market expected to reach USD 2.07 billion by 2022 : Grand View Research,Inc.

The global commercial drone market size is expected to reach USD 2.07 billion by 2022, according to a new report by Grand View Research, Inc. Increased utility in law enforcement and agricultural applications is expected to play a pivotal role in market growth over the forecast period. Having made their presence felt in the military sector, these Unmanned Aerial Vehicles (UAVs) have gradually gained prominence in the commercial sector and are foreseen to surpass the growth observed in the former.
Prominent retailers and e-commerce players have experimented the use of drones to deliver packages to consumers in a much shorter duration as compared to the traditional delivery media. The use of drones for retail is pending government approval, particularly in the U.S. Once regulatory clearance is obtained, drones are expected to revolutionize the retail sector.
Browse full report by Grand View Research :
http://www.grandviewresearch.com/industry-analysis/global-commercial-drones-market
Further key findings from the study suggest:
  • Government applications which include law enforcement, infrastructure, and research & development contributed to over 40% of the market revenue in 2014. Commercial drones have garnered importance in search and rescue missions, scientific research, and mapping. Agriculture is expected to emerge as a lucrative application sector over the forecast period. These UAVs aid farmers by taking snapshots of a vast array of fields and providing crucial data pertaining to soil and crops, thereby assisting in crop management. Use of UAVs in retail is expected to transform the industry dynamics and is foreseen to positively shape market growth.
  • Rotary blade drone accounted for over 75% of the market share in 2014. Its popularity can be attributed to the fact that it is capable of flying in every direction as well as hovering in a fixed position, which its fixed wing counterparts cannot achieve. Fixed wing drone is more suited for aerial mapping, undertaking topographic surveys, and terrain modeling of larger areas which include stockpiles & mine sites.
  • North America contributed to over 55% of the global revenue in 2014, which can be attributed to high production and increased use in law enforcement and agricultural activities. The regulatory scenario is Europe is more conducive to market growth as opposed to the U.S., which is expected to play a pivotal role in high penetration of commercial drones in Europe. Asia Pacific stands to witness high proliferation of commercial UAVs over the forecast period. Countries such as Japan and Australia have emphasized on the use of UAVs in agriculture.
  • Key market participants include Parrot SA, The Boeing Company, Textron Inc., Northrop Grumman, Lockheed Martin Corporation, Israel Aerospace Industries, General Atomics, Elbit Systems Ltd., DJI, BAE Systems PLC, and AeroVironment Inc. Strategic alliances with government agencies and collaborations with prominent technology providers are some of the strategic steps taken by market players to gain a foothold in the industry.
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/emerging-and-next-generation-technologies
For the purpose of this study, Grand View Research has segmented the global commercial drone market on the basis of product, application, and region:
Commercial Drone Product Outlook (Revenue, USD Million, 2012 - 2022)
  • Fixed wing
  • Rotary blade
  • Nano
  • Hybrid
Commercial Drone Application Outlook (Revenue, USD Million, 2012 - 2022)
  • Agriculture
  • Energy
  • Government
  • Media & Entertainment
  • Others
Commercial Drone Regional Outlook (Revenue, USD Million 2012 - 2022)
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA
Access press release by Grand View Research: http://www.grandviewresearch.com/press-release/commercial-drone-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: http://www.grandviewresearch.com




Microfluidics market is Projected to reach USD 10 billion by 2024 : Grand View Research , Inc.

The global microfluidics market is expected to reach USD 10 billion by 2024, according to a new report by Grand View Research, Inc. The demand for this sector is expected to upsurge due to the introduction of improved technology, such as digital microfluidics, which enables on-chip biochemical analysis.
Industry players are introducing newer sampling technologies to meet the demand for screening a huge number of biological samples. For instance, in March 2014, Dolomite launched Mitos Dropix capable of generating miniature droplets to isolate contents. The patented droplet picking technology enables high-throughput sample screening.
Moreover, researchers are continuously striving to come up with improved sample droplet production techniques. For instance, Columbia University introduced the picoliter fluid dispensation technology. This lab-on-chip technology could deliver sample volume less than 50 nL. Integrating microfluidics with multiplexed sensing technology allows multiple sample analytical application.


Further Key Findings From the Study Suggests:
  • In Vitro Diagnostic (IVD) segment dominated the application segment owing to the increasing adoption of microfluidics in this market.  Moreover, the leaders in the diagnostics sector, such as Abbott, Roche, and Danaher are encouraging the use of newer microfluidics technologies, such as the monodisperse bubbles/drops.
  • Novel drug delivery system requires the administration of the drug in the form of nanoparticles, thereby reducing the onset of action. Devices such as microneedles, pumps, and inhalers are expected to experience fastest growth during the forecasted period.
  • Polymers had the largest revenue share in 2015. Polymers offer better temperature control as compared to glass. However, silicon material is expected to witness fastest growth owing to the dominance of point-of-care diagnostics in the microfluidics market. Moreover, the growing demands for faster results with minimally invasive tools are expected to boost growth of this sector.
  • North America dominated the market in 2015. It is attributed to the presence of strong research capital, introduction of improved sample volume screening techniques, and presence of dominant market players.
  • In June 2016, Roche received 510 (K) clearances for Elecsys BRAHMS PCT assay. With this launch, Roche became the only company to offer integrated solutions: the assessment and management of sepsis risk. The biomarker was developed to offer a solution for the 1.6 million annual hospitalizations.
  • Asia Pacific is expected to witness fastest growth owing to the increasing aging population, repeated hospital visits, presence of untapped market, and the low cost of labor. These factors have attracted many international players to establish their research laboratories in India and China.
  • The industry is also experiencing many mergers and acquisitions between competitors. In July 2015, IDEX Corporation acquired CIDRA Precision Services, LLC. CIDRA Precision Services, LLC is a manufacturer of microfluidics devices and the acquisition is expected to accelerate IDEX growth in the microfluidics space.
  • Some key players are Illumina, Inc.; Agilent Technologies; Caliper Life Sciences (acquired by PerkinElmer, Inc.); Cepheid; Danaher Corporation; Life Technologies Corporation (acquired by Thermo Fisher Scientific, Inc.);Bio-Rad Laboratories, Inc.; Abbott Laboratories; F. Hoffmann-La Roche Ltd; and Fluidigm Corporation.
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global microfluidics market on the basis of application, material and region:
Microfluidics Application Outlook (Revenue, USD Million, 2013 - 2024)
  • Pharmaceutical
    • Genomics
    • Proteomics
    • Cell based assays and others
  • In-Vitro Diagnostics (IVD)
    • POC
    • Clinical
    • Environmental and industrial
  • Medical Devices
Microfluidics Material Outlook (Revenue, USD Million, 2013 - 2024)
  • Polymer
  • Glass
  • Silicon
  • Metal, Ceramics and others
Microfluidics Regional Outlook (Revenue, USD Million, 2013 - 2024)
  • North America
    • S.
    • Canada
  • Europe
    • UK
    • Germany
    • Rest of Europe
  • Asia Pacific
    • India
    • Japan
    • China
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • MEA
    • South Africa
 Access press release by Grand View Research:  http://www.grandviewresearch.com/press-release/global-microfluidics-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: http://www.grandviewresearch.com

3D bioprinting market is projected to reach USD 1.82 billion by 2022 : Grand View Research,Inc.

Global 3D bioprinting market is expected to reach USD 1.82 billion by 2022, according to a new report by Grand View Research Inc. Rising prevalence of chronic diseases such as Chronic Kidney Disease (CKD) which demands kidney transplantation is expected to boost the market growth, as 3D bioprinting is convenient and cost effective substitute for organ transplantation. 
Emerging medical applications of 3D bioprinting such as toxicity testing, drug discovery, tissue engineering and consumer product testing are expected to further drive the market growth positively. Increasing R&D expenditure is anticipated to be high impact rendering driver for the industry. 3D bioprinting advances in tissue engineering and allows developments to be done using biomaterials which have better biocompatibility. Moreover, rising geriatric population is expected to assist the market growth, as this demographic is highly susceptible to age related organ deformities.
Browse full report by Grand View Research :
Further key findings from the study suggest:
·         Syringe based printers dominated the technology segment as these printers allow working in sterile environment. Moreover, syringe based printers have wide applications which include fabrication of scaffolds, cell strips printing, and tissue printing.
·         Magnetic levitation based printers are expected to witness lucrative growth over the forecast period. This can be attributed to emerging medical applications such as screening of cardiovascular toxicity, human cell modeling and smooth muscle printing.
·         The medical applications segment is expected to gain substantial share of over 32.0% by 2022 which can be attributed to emerging applications of 3D bioprinting such as toxicity screening, organ transplants and medical pills.
·         Dental application segment is expected to witness lucrative growth over the forecast period. Rising demand for cosmetic dentistry along with growing awareness about oral hygiene are expected to foster the demand for dental applications.
·         North America dominated the regional 3D bioprinting market with over 35.0% share and is expected to grow at a CAGR of 10.0%. Supportive government initiatives to improve healthcare infrastructure coupled with growing disposable income are vital driving factor for this region’s growth.
·         Asia Pacific is expected to witness lucrative growth over the forecast period. Favorable government support to improve healthcare delivery with economic developments in emerging countries such as India and China are expected to increase the demand for 3D bioprinting.
·         Key players operating in the 3D bioprinting industry include Organovo Holding Inc., Cyfuse Biomedical, BioBots, Luxexcel Group BV, TeVido BioDevices, Aspect Biosystems, 3Dynamics Systems, Stratasys Ltd., Voxeljet, Oceanz, Materialise NV, Envision TEC, Bio3D Technologies, Solidscape and others.  
·         These players are involved in various strategic initiatives such as new product launches, strategic alliances and mergers and acquisitions to gain the edge over the competitors. For instance, In June 2015, Orgonovo collaborated with L’Oreal to develop skin tissue using NovoGen Bioprinting platform.
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global 3D bioprinting market on the basis of products and region:
 3D Bioprinting Market Technology Outlook (USD million), 2012 - 2022
·         Magnetic levitation
·         Inkjet based
·         Syringe based
·         Laser based
·         Other
3D Bioprinting Market Application Outlook (USD million), 2012 - 2022
·         Medical
o    Tissue and organ generation
o    Medical pills
o    Prosthetics and implants
·         Dental
·         Biosensors
·         Consumer/Personal products testing
·         Bioinks
·         Food and animal product bioprinting
3D Bioprinting Market Regional Outlook (USD million), 2012 - 2022
·         North America
o    U.S.
o    Canada
·         Europe
o    UK
o    Germany
·         Asia Pacific
o    Japan
o    China
·         Latin America
o    Brazil
·         MEA
o    South Africa.
View Press Release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-3d-bioprinting-market


 About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.


For More Information: www.grandviewresearch.com

Synthetic paper market expected to reach USD 454.5 million by 2024 : Grand View Research,Inc.

The global synthetic paper market is expected to reach USD 454.5 million by 2024, according to a new report by Grand View Research, Inc. Synthetic paper is an eco-friendly alternative to the conventional wood pulp based paper. Growing consumer awareness regarding utilization of environmentally friendly products and supportive government regulations are likely to propel growth over the forecast period.
Manufacturers have been involved in extensive R&D to produce the synthetic paper which is water and tear resistant, scuff resistant, and provides easy printability. Technological advancement in printing technologies is also likely to propel its growth over the next eight years. Inkjet technology is one of the most popular printing techniques for the synthetic paper.
Browse full report by Grand View Research :
Further key findings from the report suggest:
·         BOPP segment dominated the global synthetic paper market and was over USD 140.0 million in 2015. Cost effectiveness and superior properties are likely to propel its growth over the forecast period. The HDPE segment is expected to witness significant growth on account of its growing utilization for labeling in numerous industries.
·         Non-label application was valued at over USD 150.0 million in the global market in 2015. The label application was estimated to grow at a significant pace owing to stringent government regulations regarding food & beverage labeling, which is expected to lead to increased utilization over the forecast period.
·         Asia Pacific dominated the market and was valued at over USD 90.0 million in 2015. Growing manufacturing sector in the region has led to increasing demand for the product from its applications. Japan, Taiwan, China, India, and Australia are key economies leading to market growth. Many synthetic paper manufacturers in North America and Europe have been focusing on expanding their businesses in the region on account of low cost and availability of skilled labor.
·         In October 2014, PPG Industries developed a new website for its TESLIN substrate, which is a highly durable synthetic paper. This step has led to easy accessibility of the product worldwide. Similarly, In November 2014, Tagleef Industries acquired Derprosa Film. This move has helped the company to increase its global reach. The company has been involved in R&D to develop the innovative product to strengthen its market position. It has three manufacturing facilities in the Middle East, two in Europe, one in the U.S., one in Australia, and distribution and sales center in Germany and China.
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/plastics-polymers-and-resins
Grand View Research has segmented the global synthetic paper market on the basis of product, application and region:
  Global Synthetic Paper Product Outlook (Volume, Kilo tons; Revenue, USD Million, 2013 - 2024)
·         BOPP
·         HDPE
·         Others
  Global Synthetic Paper Application Outlook (Volume, Kilo tons; Revenue, USD Million, 2013 - 2024)
·         Label
·         Non-Label
  Global Synthetic Paper Regional Outlook (Volume, Kilo tons; Revenue, USD Million, 2013 - 2024)
·         North America
o    U.S.
o    Canada
o    Mexico
·         Europe
o    Germany
o    UK
o    France
o    Italy
·         Asia Pacific
o    China
o    Japan
o    Taiwan
o    India
o    Australia
·         Latin America
o    Brazil
·         Middle East & Africa
View Press Release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-synthetic-paper-market


 About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com


Dietary supplements market Expected to reach USD 278.02 billion by 2024 : Grand View Research,Inc.

The global dietary supplements market is expected to reach USD 278.02 billion by 2024, according to a new report by Grand View Research, Inc. Favorable outlook towards medical nutrition market in light of increasing application for the treatment of malnutrition and cardiovascular disorders is likely to promote the market for dietary supplements.
Rising sales of sports nutrition products in the U.S. and China on account of increasing prevalence of fitness and sports at a domestic level along with new product launches is likely to have a significant impact on the industry over the projected period. The market is expected to generate revenues worth USD 37.16 billion by 2024.
Rising consumption of clinical nutrition products as a prevention medium for reducing malnutrition is expected to have a substantial impact. Furthermore, increasing prevalence of premature births on a global level is expected to promote the use of medicinal supplements over the forecast period. The market was worth USD 19.17 billion in 2015 and is projected to witness growth at a CAGR of 9.5% from 2016 to 2024.
Further key findings from the report suggest:
·         The market for dietary supplement capsules was valued at USD 26.42 billion in 2015. The increasing use of omega-3 fatty acids in the formulation of dietary supplement capsules is expected to have a positive impact over the forecast period.
·         Amino acid-based dietary supplements accounted for 14.3% of the market share in 2015 and is projected to witness significant growth on account of increasing protein intake by bodybuilders and sports athletes
·         Gel caps and soft gels together accounted for 13.2% of the overall market in 2015. These products are expected to witness growth on account of their increasing application in confectionaries including chocolates, candies, and desserts.
·         Asia Pacific is projected to growth at a CAGR of 11.2% from 2016 to 2024. Rising sales of green juice, royal jelly, blueberries, chlorella, and black vinegar in Japan owing to increasing awareness towards natural products is expected to promote the use of nutritional supplements over the forecast period.
·         North America accounted for 28.5% of the total market in 2015 and is projected to witness growth on account of increasing consumption of products with reduced calorie level and high nutritional content
·         Key participants include Amway Corporation, Pfizer Pharmaceuticals, Abbott Laboratories, Herbalife International, ADM, DuPont, and Carlyle Group. In April 2016, Amway Inc. launched a new sports nutrition energy drink under the brand name, XS Sports Nutrition line. This type of product innovation is expected to force manufacturers to develop new products over the next eight years.
Grand View Research has segmented the global dietary supplements market by ingredient, product, application, end-use and region:
Ingredient Outlook (Revenue, USD Million, 2013 - 2024)
·         Botanicals
·         Vitamins
·         Minerals
·         Amino Acids
·         Enzymes
·         Others
Product Outlook (Revenue, USD Million, 2013 - 2024)
·         Tablets
·         Capsules
·         Powder
·         Liquids
·         Soft Gels
·         Gel Caps
Application Outlook (Revenue, USD Million, 2013 - 2024)
·         Additional Supplements
·         Medicinal Supplements
·         Sports Nutrition
End-use Outlook (Revenue, USD Million, 2013 - 2024)
·         Infant
·         Children
·         Adults
·         Pregnant Women
·         Old-aged
Regional Outlook (Revenue, USD Million, 2013 - 2024)
·         North America
o    U.S.
o    Canada
o    Mexico
·         Europe
o    Germany
o    UK
o    France
o    Italy
·         Asia Pacific
o    China
o    Japan
o    India
·         Latin America
o    Brazil
·         Middle East & Africa (MEA)
o    South Africa
View Press Release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-dietary-supplements-market

 About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com